Curi Bio - Podium Presentation:
Presenter: Elliot Fisher - Chief Business Officer, Curi Bio
Session: Therapeutic Development Platforms
Date: Thursday, July 16, 2020 - 3:05 PM
Title: Human Cells, Systems, and Data to Accelerate the Discovery of New Medicines
Description: The cost to develop a single new medicine has increased 100-fold since 1953 to more than $2.3Bn. This high cost of drug development is driven by an inefficient preclinical pipeline that relies heavily on non-human models, with an overall failure rate of >80%. The advent of human stem cell technology promises to revolutionize drug development by bringing human tissues into the early stages of preclinical research, dramatically improving the likelihood that new therapies will translate from bench to bedside. Curi Bio is leveraging human stem cells, next-generation biosystems, and predictive preclinical data in a single integrated platform–the Curi Engine–to accelerate the discovery of new medicines.
For more information about the meeting, please click here.